Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190131042569N3Phase 2Completed
Phase 2, open-label, single-arm trial of propofol in migraine, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Effect of propofol on severity of migraine headache attacks and Effect of propofol on frequency of migraine headache attacks. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190131042569N3.